This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Nasus Pharma Ltd.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Pavel Kazhdan: Innovator in Pharmaceutical Composition
Introduction
Pavel Kazhdan is a notable inventor based in Yavne, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments for anaphylaxis. His work focuses on creating effective and safe methods for drug administration.
Latest Patents
Kazhdan holds a patent for a pharmaceutical composition that involves treatment with powdered intranasal epinephrine. This invention discloses a dry powder form for intranasal administration, which includes an anti-anaphylactic adrenergic receptor agonist. The composition consists of solid particles of the active agent combined with at least one functional additive and solid particles of an inert carrier. This innovative approach aims to enhance the efficacy of epinephrine in emergency situations.
Career Highlights
Throughout his career, Pavel Kazhdan has demonstrated a commitment to advancing medical treatments. His work at Nasus Pharma Ltd. has positioned him as a key player in the pharmaceutical industry. His dedication to research and development has led to breakthroughs that can potentially save lives.
Collaborations
Kazhdan collaborates with Galia Temtsin-Krayz, contributing to the innovative projects at Nasus Pharma Ltd. Their partnership exemplifies the importance of teamwork in the pursuit of medical advancements.
Conclusion
Pavel Kazhdan's contributions to pharmaceutical innovation, particularly through his patent for intranasal epinephrine treatment, highlight his role as a significant inventor in the field. His work continues to pave the way for improved medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile